tiprankstipranks
TipRanksStock Market NewsESTA NewsAnalysts Are Bullish on Top Healthcare Stocks: Rhythm Pharmaceuticals (RYTM), Establishment Labs Holdings (ESTA)
Blurbs

Analysts Are Bullish on Top Healthcare Stocks: Rhythm Pharmaceuticals (RYTM), Establishment Labs Holdings (ESTA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rhythm Pharmaceuticals (RYTMResearch Report) and Establishment Labs Holdings (ESTAResearch Report) with bullish sentiments.

Rhythm Pharmaceuticals (RYTM)

In a report released today, Joseph Stringer from Needham reiterated a Buy rating on Rhythm Pharmaceuticals, with a price target of $40.00. The company’s shares closed last Tuesday at $8.44, close to its 52-week low of $6.02.

According to TipRanks.com, Stringer ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -25.0% and a 21.6% success rate. Stringer covers the Healthcare sector, focusing on stocks such as Apellis Pharmaceuticals, Phathom Pharmaceuticals, and Lexicon Pharmaceuticals.

Rhythm Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $23.50, a 198.6% upside from current levels. In a report issued on February 17, Ladenburg Thalmann & Co. also upgraded the stock to Buy with a $15.00 price target.

See today’s best-performing stocks on TipRanks >>

Establishment Labs Holdings (ESTA)

In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Establishment Labs Holdings, with a price target of $95.00. The company’s shares closed last Tuesday at $61.62.

According to TipRanks.com, Thibault is a 5-star analyst with an average return of 22.6% and a 38.7% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Irhythm Technologies, and Pear Therapeutics.

Establishment Labs Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $95.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on RYTM:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More